Turning Point Brands (TPB) 17th Annual Midwest IDEAS Conference summary
Event summary combining transcript, slides, and related documents.
17th Annual Midwest IDEAS Conference summary
27 Aug, 2026Strategic vision and market outlook
Aims to achieve double-digit market share in the modern oral nicotine category by the end of the decade, targeting a $10 billion market size and $1 billion in sales.
Modern oral products are positioned as a growth engine, with current market share around 5% and a focus on expanding both online and bricks-and-mortar presence.
Multi-brand strategy with FRĒ and ALP targets different consumer segments, leveraging a joint venture with Tucker Carlson for ALP.
Investments are focused on scaling distribution, omni-channel reach, and marketing to drive awareness and sales.
Plans to double store count to reach 10% market share, emphasizing expansion in chain convenience stores.
Brand portfolio and competitive advantages
Operates heritage brands in tobacco (Stoker's), cannabis accessories (Zig-Zag), and modern oral (FRĒ, Nu-X, ALP), holding leading positions in several categories.
Differentiates through direct-to-consumer expertise, robust online channels, and deep retail/distributor relationships.
Modern oral products offer unique features such as moist pouches and a broad range of nicotine strengths, addressing gaps left by competitors.
FRĒ targets high-performance consumers, while ALP appeals to everyday, independent users.
Legacy brands provide stable cash flow, funding innovation and growth in emerging categories.
Financial performance and operational execution
Net sales grew from $325 million in 2023 to $463 million in 2025, with adjusted EBITDA reaching $120 million.
Modern oral segment saw 128% year-over-year growth in Q2 and a 140% CAGR since Q1 2025.
Gross margin remains stable at 57%, with future potential to reach 70% as production shifts domestically.
Leverage profile improved from 2.7x in 2023 to less than 1x in 2025.
Investments in sales force and slotting fees are front-loaded, with expected cost leverage as distribution scales.
Latest events from Turning Point Brands
- Category-leading brands and modern oral investments drive rapid growth and profitability.TPB
Investor presentation - Modern Oral sales soared 128% YoY, boosting revenue but profits fell on higher investment.TPB
Q2 2026 - Modern Oral net sales jumped 133%, driving Q1 growth and higher FY 2026 guidance.TPB
Q1 2026 - All board nominees, auditor ratification, and executive compensation were approved.TPB
AGM 2026 - Annual meeting to vote on directors, auditor, and executive pay, with emphasis on diversity and governance.TPB
Proxy filing - Modern Oral net sales jumped 266% in Q4, fueling 29% revenue growth and a strong 2026 outlook.TPB
Q4 2025 - Q3 2024 saw double-digit profit growth, raised guidance, and expanded share buybacks.TPB
Q3 2024 - Q2 sales and EBITDA rose, guidance increased, and net income jumped 31% on strong segment growth.TPB
Q2 2024 - FY2024 net sales up 11% and EBITDA up 12%, with strong modern oral and core brand growth.TPB
Q4 2024